After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.

SIOUX CITY (KTIV) - The World Health Organization says chronic obstructive pulmonary disease (COPD) is the third leading ...

The following is a summary of “Investigation of the Relationship Between the Measured Alpha Angle in Capnography and Readmission Within Thirty Days in Chronic Obstructive Pulmonary Disease Patients ...

Dupixent, a Sanofi and Regeneron Pharmaceuticals drug, is now approved for chronic obstructive pulmonary disease (COPD), a progressive lung disease prevalent in smokers. It’s the sixth FDA ...

Medically reviewed by Reza Samad, MD There are two types of lung diseases: obstructive lung disease and restrictive lung ...

Mucociliary dysfunction, chronic infections with advancing immunosenescence and pulmonary emphysema as seen in COPD may be just as relevant to ACOS. Possible drug targets include receptors of the ...

and airway remodeling associated with chronic obstructive pulmonary disease (COPD). Selective PDE4 inhibition is proposed to maximize the antiinflammatory effects of PDE inhibition while ...

Changes in people's voices recoded on a smartphone can signal a serious flare up in symptoms of chronic obstructive pulmonary disease (COPD), according to a pilot study presented at the European ...

Chronic Pulmonary Obstructive Disease: What are its symptoms and causes and why is it important to quit smoking in the current season. Some people suffer from Asthma and COPD simultaneously ...

Each year in Utah and most other western states in America, the period from July through October is considered wildfire season because it typically represents the peak times atmospherically for ...

According to the World Heath Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.